| scholarly article | Q13442814 |
| P50 | author | Dipshikha Chakravortty | Q47494288 |
| P2093 | author name string | Vidya Devi Negi | |
| Santanu Singhamahapatra | |||
| P2860 | cites work | One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 |
| Typhoid and paratyphoid fever | Q28269252 | ||
| Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia | Q33213069 | ||
| Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium | Q34004929 | ||
| Host immune response to Salmonella enterica serovar Typhimurium infection in mice derived from wild strains | Q34120673 | ||
| Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice | Q34760019 | ||
| Identification of the lipopolysaccharide modifications controlled by the Salmonella PmrA/PmrB system mediating resistance to Fe(III) and Al(III). | Q35103882 | ||
| Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection | Q36141207 | ||
| In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection | Q39522009 | ||
| The PhoP virulence regulon and live oral Salmonella vaccines. | Q40723116 | ||
| Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers | Q46685348 | ||
| A novel mechanism for connecting bacterial two-component signal-transduction systems | Q50093509 | ||
| Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors | Q50105772 | ||
| Co-localization of quantitative trait loci regulating resistance to Salmonella typhimurium infection and specific antibody production phenotypes | Q50106268 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella enterica | Q2264864 |
| P304 | page(s) | 5315-5323 | |
| P577 | publication date | 2007-06-04 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model. | |
| P478 | volume | 25 |
| Q28748972 | A safe vaccine (DV-STM-07) against Salmonella infection prevents abortion and confers protective immunity to the pregnant and new born mice |
| Q34532843 | Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice |
| Q26782563 | Gas Vesicle Nanoparticles for Antigen Display |
| Q36509587 | Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteria |
| Q34515009 | Haloarchaeal gas vesicle nanoparticles displaying Salmonella antigens as a novel approach to vaccine development |
| Q37309260 | Lipopolysaccharide: a tool and target in enterobacterial vaccine development |
| Q30501618 | Needleless vaccine delivery using micro-shock waves |
| Q43486308 | Parenteral administration of attenuated Salmonella Typhimurium ΔznuABC is protective against salmonellosis in piglets. |
| Q47590249 | Protective efficacy of a Salmonella Typhimurium ghost vaccine candidate constructed with a recombinant lysozyme-PMAP36 fusion protein in a murine model |
| Q58600076 | Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis |
| Q39673802 | Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice |
| Q47840879 | SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria |
| Q37996843 | Typhoid fever & vaccine development: a partially answered question. |
Search more.